Dr Steve Chatfield
Chairman of the Board
Steve is Chairman of the Board of Prokarium and brings more than 30 years of experience in the biopharmaceutical industry, developing vaccines in small and large businesses, most recently as Executive Vice President, Strategic Investments at one of the top 20 vaccine companies in the World; Emergent BioSolutions.
Steve has also served as Executive Director of the U.K. Health Protection Agency (now Public Health England) and has held posts at Medeva and the Wellcome Foundation. In his career he has focused on the development of products to prevent and treat infectious disease and is internationally recognized as an opinion leader in the biotechnology field with more than 100 scientific papers on biotechnology.